• FirefoxInstall the new Firefox »
  •  Dow Down 0.44% Nasdaq Down 0.42%

    Actavis plc (ACT)

    -NYSE
    296.43 Down 1.19(0.40%) 4:03PM EDT
    |After Hours : 296.38 Down 0.05 (0.02%) 5:10PM EDT
    Add to Portfolio
    Prev Close:297.62
    Open:299.51
    Bid:296.38 x 100
    Ask:299.90 x 100
    1y Target Est:340.90
    Beta:0.84
    Earnings Date:Apr 28 - May 4 (Est.)
    Day's Range:292.82 - 299.77
    52wk Range:184.71 - 317.72
    Volume:4,494,828
    Avg Vol (3m):3,288,830
    Market Cap:78.93B
    P/E (ttm):N/A
    EPS (ttm):-7.42
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Related Video

    Headlines

    » More Headlines for ACT

    Comparison

    Symbol% ChgMkt Cap
    ACTDown 0.40%78.93B
    MYLDown 2.38%21.92B
    NVSUp 1.27%239.53B
    TEVAUp 0.39%53.28B

    Key Statistics

    Forward P/E (1 yr):13.95
    P/S (ttm):6.07
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :17.60
    Quarterly EPS Est (Mar-15) :4.03
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):0.94

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Actavis plc develops, manufactures, and sells generic, brand, and biosimilar pharmaceuticals. It offers over-the-counter products. The company also provides biosimilar products in women’s health, oncology, and other therapeutic categories. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback